Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 15 von 29
The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-07, Vol.8 (7), p.2263-2274.e5
2020
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure
Ist Teil von
  • The journal of allergy and clinical immunology in practice (Cambridge, MA), 2020-07, Vol.8 (7), p.2263-2274.e5
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2020
Quelle
MEDLINE
Beschreibungen/Notizen
  • Asthma exacerbation risk increases with worsening asthma control. Prevailing numerical control tools evaluate only current symptom impairment despite the importance of also assessing risk based on exacerbation history. An easy-to-use questionnaire addressing impairment and risk domains of control is needed. To validate a composite asthma control tool that includes impairment and risk assessments (Asthma Impairment and Risk Questionnaire [AIRQ]). Four-hundred forty-two patients aged ≥12 years with physician-diagnosed asthma who were followed in specialty practices completed 15 impairment and risk questions with dichotomized yes/no responses. Patients spanned all Global Initiative for Asthma severities and were classified as well-controlled, not well-controlled, or very poorly controlled according to a standard of Asthma Control Test (ACT) score plus prior-year exacerbations. Logistic regression analyses identified questions with the greatest predictive validity to discriminate among patients and determine cut points for these 3 classifications. The final AIRQ comprises 10 equally weighted yes/no impairment and risk questions. The final 10-item models yielded receiver operating characteristic curves of 0.94 to identify well-controlled versus not well-/very poorly controlled and 0.93 to identify well-/not well-controlled versus very poorly controlled asthma, as reflected by the ACT plus prior-year exacerbations standard. Cut points of 0-1, 2-4, and 5-10 best represented well-, not well-, and very poorly controlled asthma. AIRQ is a rigorously validated composite measure designed to identify adults and adolescents with varying degrees of asthma control. Ongoing investigations will determine test-retest reliability, responsiveness to change, and predictive ability for future exacerbations.
Sprache
Englisch
Identifikatoren
ISSN: 2213-2198
eISSN: 2213-2201
DOI: 10.1016/j.jaip.2020.02.042
Titel-ID: cdi_proquest_miscellaneous_2401110331

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX